Episode Details
Back to Episodes
Sellas Reports Promising AML Phase 2, Promising Ropeginterferon Boosts Blood Cancer Therapy, Cosmic Knots Reveal Matter Origins, Regeneron Drug Promises in MY Health, and more...
Published 4 months, 1 week ago
Description
(0:10): SELLAS Life Sciences Reports Promising Phase 2 Results for AML Treatment at ASH 2025
(2:33): AOP Health Showcases Promising Ropeginterferon Results for Blood Cancer Treatment at ASH Meeting
(5:17): Japanese Physicists Propose Cosmic Knots Theory to Solve Matter Origin Mysteries
(7:39): Regeneron's Lynozyfic Shows Promise as Frontline Therapy for Multiple Myeloma in LINKER Trials
(10:11): Groundbreaking Study Maps Gut-Liver Pathway, Paving New Avenues for Diabetes and Obesity Treatment
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: SSBCrack News
(2:33): AOP Health Showcases Promising Ropeginterferon Results for Blood Cancer Treatment at ASH Meeting
(5:17): Japanese Physicists Propose Cosmic Knots Theory to Solve Matter Origin Mysteries
(7:39): Regeneron's Lynozyfic Shows Promise as Frontline Therapy for Multiple Myeloma in LINKER Trials
(10:11): Groundbreaking Study Maps Gut-Liver Pathway, Paving New Avenues for Diabetes and Obesity Treatment
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: SSBCrack News